Immunohistochemistry (IHC) analysis of samples from 77 patients with pancreatic cancer revealed that the NAT10 protein was predominantly localized in tumor cell nuclei and was significantly elevated in cancerous tissues compared to adjacent normal tissues (Fig. 1I, left panels). This evidence concerns the gene NAT10 and pancreatic neoplasm.